RCC-77409-31751
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Moderna
-
2021-02-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-07
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-20
- 2021-02-27
- 2021-03-07
- 2021-03-13
-
2021-03-16
Dose 2 — Moderna
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-26
- 2021-03-30
- 2021-04-07
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-06-15
- 2021-09-14
-
2021-12-27
Dose 3 — Moderna
- 2021-12-31
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-01-24
-
2022-01-31
Survey response — day 35, dose 3MedDRA: Headache, Lymphadenopathy, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose, sour throat, head ache, swollen lymph nodes in neck areaMedDRA releases: 2024-11 · check-in free text available
- 2022-02-09
- 2022-03-28
-
2022-06-27
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-28
-
2022-06-28
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Moderna | |
| 2 | 2021-03-16 | Moderna | |
| 3 | 2021-12-27 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — day 35, dose 3
Symptoms: Runny nose, sour throat, head ache, swollen lymph nodes in neck area
Release 12 — 6 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release